Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
- 1 January 2001
- journal article
- review article
- p. 23-5
Abstract
It is well known that serotonergic function is related to aggression. Patients with Alzheimer's disease exhibit aggressive behavior, and alterations in their serotonergic function have been identified. Recent clinical trials involving new antipsychotic agents, such as risperidone, which has both serotonergic and dopaminergic activity, have demonstrated the efficacy and safety of these drugs in treating the psychosis and aggressive behavior associated with dementia.This publication has 0 references indexed in Scilit: